Stay updated on TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial
Sign up to get notified when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.

Latest updates to the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe site footer revision shows v3.6.3, replacing the previous v3.6.2. This indicates a new software release for the ClinicalTrials.gov interface, likely including fixes or enhancements.SummaryDifference0.0%

- Check12 days agoChange DetectedExpanded the study’s location network to 260 sites by adding several new centers (eg Hospital da Luz in Lisbon; Hubei Cancer Hospital in Wuhan; Tianjin Medical University General Hospital; The Second Peoples Hospital of Neijiang; Haikou Peoples Hospital; Saiseikai Matsusaka Municipal Hospital) across multiple countries. The deletions remove Matsusaka Municipal Hospital and Adana Baskent University, and the total location count changes from 254 to 260.SummaryDifference0.5%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRecruitment status updated to indicate the study is no longer enrolling, and new navigation/help sections were added while a few header labels were adjusted; these changes mainly affect how users access information rather than altering the trial's design or outcomes.SummaryDifference0.1%

- Check33 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5. This appears to be a minor metadata/UI update with no changes to study details, eligibility criteria, or results.SummaryDifference0.0%

- Check55 days agoChange DetectedA new revision tag, v3.5.4, has been added and the previous tag, v3.5.3, removed, updating the page's version history.SummaryDifference0.0%

- Check62 days agoChange DetectedThe Taoyuan District entry was replaced with Taoyuan in the Taiwan location list (code 333), standardizing the city label without changing the site code.SummaryDifference0.0%

Stay in the know with updates to TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.